Skip Nav Destination
About the Journal
Molecular Cancer Therapeutics publishes articles on the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanism of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms.. Read More About the Journal
Impact Factor
6.261
Featured Articles
Trending - Altmetric
Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity
Last mentioned on Monday May 23 2022
Tissue Agnostic Activity of BRAF plus MEK inhibitor in BRAF V600 mutant tumors
Last mentioned on Sunday May 22 2022
PLGA-nano-encapsulated Disulfiram inhibits hypoxia-induced NFκB, cancer stem cells and targets glioblastoma in vitro and in vivo
Last mentioned on Monday May 23 2022
A Preclinical Study to Repurpose Spironolactone for Enhancing Chemotherapy Response in Bladder Cancer
Last mentioned on Monday May 23 2022
Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells
Last mentioned on Monday May 23 2022